[1] SEMENZA G L.Hypoxia-inducible factor 1 and cardiovascular disease[J]. Annu Rev Physiol, 2014(76): 39-56. [2] HU J, STIEHL D P, SETZER C, et al. Interaction of HIF and USF signaling pathways in human genes flanked by hypoxia-response elements and E-box palindromes[J]. Mol Cancer Res, 2011, 9(11): 1520-1536. [3] SOUSA FIALHO M D L, ABD JAMIL A H, STANNARD G A, et al. Hypoxia-inducible factor 1 signalling, metabolism and its therapeutic potential in cardiovascular disease[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(4): 831-843. [4] YU H L,CHEN B,REN Q.Baicalin relieves hypoxia-aroused H9c2 cell apoptosis by activating Nrf2/HO-1-mediated HIF1α/BNIP3 pathway[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 3657-3663. [5] BENARD G, NEUTZNER A, PENG G, et al. IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation[J]. EMBO J, 2010, 29(8): 1458-1471. [6] DARBY I A,HEWITSON T D.Hypoxia in tissue repair and fibrosis[J]. Cell Tissue Res, 2016, 365(3): 553-562. [7] LI M, CUI Y, HE W, et al. Effects of triple-mutated hypoxia-inducible factor-1α on angiogenesis and cardiac function improvement in rats with myocardial infarction[J]. Cell Physiol Biochem, 2018, 50(6): 2329-2340. [8] NECKÁŘ J, HSU A, HYE KHAN M A, et al. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3[J]. Am J Physiol Heart Circ Physiol, 2018, 315(5): H1148-H1158. [9] HÖLSCHER M, SCHÄFER K, KRULL S, et al. Unfavourable consequences of chronic cardiac HIF-1α stabilization[J]. Cardiovasc Res, 2012, 94(1): 77-86. [10] MOSLEHI J, MINAMISHIMA Y A, SHI J R, et al. Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy[J]. Circulation, 2010, 122(10): 1004-1016. [11] KUMAR S, WANG G, LIU W, et al. Hypoxia-induced mitogenic factor promotes cardiac hypertrophy via calcium-dependent and hypoxia-inducible factor-1α mechanisms[J]. Hypertension, 2018, 72(2): 331-342. [12] LEI L, MASON S, LIU D, et al. Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein[J]. Mol Cell Biol, 2008, 28(11): 3790-3803. [13] NG C C, ARAKAWA H, FUKUDA S, et al. p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1[J]. Oncogene, 2003, 22(28): 4449-4458. [14] CONFORTI F, YANG A L, PIRO M C, et al. PIR2/Rnf144B regulates epithelial homeostasis by mediating degradation of p21WAF1 and p63[J]. Oncogene, 2013, 32(40): 4758-4765. [15] 裴静娴,王月刚,张艺军,等.p53RFP基因启动子荧光素酶报告基因载体的构建及鉴定[J]. 广东医学, 2017, 2(38): 170-172. |